Skip to content

Laparoscopic Adjustable Gastric Banding in Adolescents

Laparoscopic Adjustable Gastric Banding for Treatment of Morbid Obesity in Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01619488
Enrollment
57
Registered
2012-06-14
Start date
2007-04-23
Completion date
2016-04-04
Last updated
2023-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Keywords

Lap-Band, morbid obesity, adolescents

Brief summary

This study is to determine if the Lap-band system is safe and effective for use in morbidly obese adolescents.

Detailed description

This study is to determine if the Lap-band system is safe and effective for use in morbidly obese adolescents

Interventions

Surgical placement of an adjustable gastric band around the upper portion of the stomach. Adjustments are made to the band through a subcutaneous port as needed to maintain appropriate restriction.

Sponsors

Kirk Reichard
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* ages 14-19 * BMI \> 35 * history of obesity for at least 5 years with failed attempts at diet and medical management for at least 6 months. * confirmation by a pediatric psychologist that the subject is sufficiently mature emotionally and has adequate family support to comply with the study protocol.

Exclusion criteria

* history of congenital or acquired anomalies of the GI tract. * history of esophageal motility disorders * uncontrolled psychiatric problems * previous esophageal, gastric or bariatric surgery; intestinal obstruction or peritonitis. * uncontrolled eating disorders

Design outcomes

Primary

MeasureTime frameDescription
Total Weight LossUp to five years post surgery.Weight loss in kilograms Weight on day of surgery minus last weight recorded before end of trial

Secondary

MeasureTime frameDescription
Insulin ResistanceBaselineFasting insulin level

Countries

United States

Participant flow

Recruitment details

Eligible patients were recruited from the pediatric weight management clinic.

Pre-assignment details

Of 136 eligible patients, 57 completed the pre-intervention program and underwent placement of the gastric band. The remainder opted out of the intervention.

Participants by arm

ArmCount
Gastric Band
Lap Band Surgery was ultimately performed on 57 patients, the remainder chose alternative management.
57
Total57

Baseline characteristics

CharacteristicGastric Band
Age, Categorical
<=18 years
56 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
1 Participants
Age, Continuous16.05 years
STANDARD_DEVIATION 1.22
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
16 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
37 Participants
Region of Enrollment
United States
57 participants
Sex: Female, Male
Female
48 Participants
Sex: Female, Male
Male
9 Participants
Weight139.36 Kilogram
STANDARD_DEVIATION 19.7

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 57
other
Total, other adverse events
0 / 57
serious
Total, serious adverse events
2 / 57

Outcome results

Primary

Total Weight Loss

Weight loss in kilograms Weight on day of surgery minus last weight recorded before end of trial

Time frame: Up to five years post surgery.

ArmMeasureValue (MEAN)Dispersion
Weight LossTotal Weight Loss11.35 kilogramsStandard Deviation 19.08
Secondary

Insulin Resistance

Fasting insulin level

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Weight LossInsulin Resistance12.5 uIU/mlStandard Deviation 14

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026